Publicaciones en colaboración con investigadores/as de Oregon Health & Science University (5)

2008

  1. Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development

    Hepatology, Vol. 48, Núm. 2, pp. 487-496

2003

  1. Pharmacologic or genetic ablation of maleylacetoacetate isomerase increases levels of toxic tyrosine catabolites in rodents

    Biochemical Pharmacology, Vol. 66, Núm. 10, pp. 2029-2038

1999

  1. Disruption of phacA, an Aspergillus nidulans gene encoding a novel cytochrome P450 monooxygenase catalyzing phenylacetate 2-hydroxylation, results in penicillin overproduction

    Journal of Biological Chemistry, Vol. 274, Núm. 21, pp. 14545-14550

  2. Gene structure, chromosomal location, and expression pattern of maleylacetoacetate isomerase

    Genomics, Vol. 58, Núm. 3, pp. 263-269

  3. Identification of the mutation in the alkaptonuria mouse model. Mutations in brief no. 216. Online.

    Human mutation, Vol. 13, Núm. 2, pp. 171